Early outcomes of endovascular repair of aortic arch lesions in zone 0/1 with a thoracic branched endoprosthesis
Journal of Vascular Surgery · 2025-11 · 82 (5) · 1591-1600.e4
DOI: 10.1016/j.jvs.2025.07.040 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Journal of Vascular Surgery, 2025-11. Verfasst von Matthew P Sweet und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Washington, Seattle, WA. Electronic address: mpsweet@uw.edu. Hauptthemen laut MEDLINE: Aorta, Thoracic, Aortic Aneurysm, Thoracic, Aortic Diseases, Blood Vessel Prosthesis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: The pivotal trial 30-day outcomes of the GORE TAG Thoracic Branch Endoprosthesis in patients with endovascular repair of the aortic arch or descending thoracic aorta using a zone 0 or 1 landing zone were evaluated. METHODS: In this nonrandomized, multicenter, prospective study, the primary, clinically driven outcome was a composite of the following through 1 month: technical success (successful device deployment with maintenance of side-branch patency and the absence of aortic rupture), lesion-related mortality, disabling stroke, permanent paraplegia or paraparesis, new onset renal failure requiring permanent dialysis, and protocol-defined unanticipated reintervention. RESULTS: The 77 study patients enrolled had aneurysm (n = 50), dissection (n = 24), or other isolated lesion types (n = 3); 90.9% of cases used a zone 0 proximal landing zone. Patients had a mean age of 70.8 ± 10.8 years; 66.2% were male and 57.1% White. All patients had both the aortic and side branch (SB) components implanted; 53 (68.8%) had a GORE TAG Conformable Thoracic Stent Graft distal extension, 20 (26.0%) required more than one device, and 6 (7.8%) had a proximal aortic extender. A single GORE TAG Thoracic Branch Endoprosthesis SB was implanted in 55 patients (71.4%), and 22 (28.6%) required more than one SB device. Technical success was achieved in 73 of 77 patients (94.8%); access site complications occurred in 4 patients. Of the patients with imaging, 77.8% (56 of 72) had successful aneurysm or primary entry tear exclusion (dependent on treated pathology) and were free from clinically evident stroke or other adverse outcomes at 30 days. In 16 of 72 patients, protocol-defined major adverse events included 3 (3.9%) lesion-related deaths, 6 (7.8%) strokes (1 died and 5 were with neurologic sequelae persistent at the 30-day cutoff), 4 (5.2%) unplanned additional procedure, and 1 renal failure. Four (6.0%) patients had type I or type III endoleak. There were no aortic ruptures or permanent paraplegia or paraparesis. CONCLUSIONS: This early experience pivotal trial demonstrates that repair of aortic arch pathology using a single SB endograft requiring proximal zone 0/1 placement had excellent treatment success and an acceptable level of perioperative complications in a cohort of patients deemed to be at high risk of open repair. Stroke and access site complications were the most frequent serious events and occurred more frequently in the aneurysm cohort. These initial data suggest that endovascular treatment of the arch is a suitable treatment option in appropriate patients. Longer-term follow-up will be required to establish how these results compare with open repair among similar patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Washington, Seattle, WA. Electronic address: mpsweet@uw.edu.
- Division of Vascular Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
- Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX.
- Division of Cardiac Surgery, Department of Cardiothoracic Surgery, Baylor Scott & White Cardiac Surgery Specialists, Plano, TX.
- Division of Vascular Surgery, University of Colorado School of Medicine, Aurora, CO.
- Jikei University Hospital, Minato, Tokyo, Japan.
Zitieren
APA
Sweet, M. P., Azizzadeh, A., Oderich, G. S., Brinkman, W., Matsumura, J. S., Ohki, T., Zettervall, S., Miyamoto, S., Patel, H. J., & Dake, M. D. (2025). Early outcomes of endovascular repair of aortic arch lesions in zone 0/1 with a thoracic branched endoprosthesis. Journal of Vascular Surgery, 82(5), 1591-1600.e4. https://doi.org/10.1016/j.jvs.2025.07.040
Vancouver
Sweet MP, Azizzadeh A, Oderich GS, Brinkman W, Matsumura JS, Ohki T, et al. Early outcomes of endovascular repair of aortic arch lesions in zone 0/1 with a thoracic branched endoprosthesis. Journal of Vascular Surgery. 2025;82(5):1591-1600.e4. doi:10.1016/j.jvs.2025.07.040
BibTeX
@article{Sweet2025,
author = {Sweet, Matthew P and Azizzadeh, Ali and Oderich, Gustavo S and Brinkman, William and Matsumura, Jon S and Ohki, Takao and Zettervall, Sara and Miyamoto, Shinji and Patel, Himanshu J and Dake, Michael D},
title = {Early outcomes of endovascular repair of aortic arch lesions in zone 0/1 with a thoracic branched endoprosthesis},
journal = {Journal of Vascular Surgery},
year = {2025},
volume = {82},
number = {5},
pages = {1591--1600.e4},
doi = {10.1016/j.jvs.2025.07.040}
}
EUVIMED